Exchange Announcement • 24 Sep 2026 16:53
2026 Interim Report
Exchange Announcement • 11 Sep 2026 07:00
Voluntary Announcement New Drug Application Of Ot-301 Accepted By The National Medical Products Administration
Exchange Announcement • 02 Sep 2026 20:13
Voluntary Announcement Patient Enrollment Completed In The Phase Iii Clinical Trial Of Ot-211
Exchange Announcement • 01 Sep 2026 19:58
Voluntary Announcement Acceptance Of Application For Drug Registration Of Domestically Produced Dexamethasone Intraocular Suspension
Exchange Announcement • 31 Aug 2026 18:23